AstraZeneca To Acquire Omthera Pharmaceuticals For $12.70/Share

AstraZeneca PLC

announced its plans to acquire Omthera Pharmaceuticals

for $12.7 per share, or around $323 million. The offer price represents an 88% premium to Omthera's closing price on May 24. The deal is likely to close in the third quarter of 2013. AstraZeneca shares gained 1.71% to $53.06 in pre-market trading, while Omthera shares closed at $6.77 on Friday.